跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,686 条关于
“ATR/Chk1”
全部
5,686
临床试验
3,239
药物
437
机构
106
资讯
1,904
去年
Circle Pharma to Reveal Dual Mechanism of Novel Cyclin A/B RxL Inhibitors at AACR 2025
去年
CytoSorbents' DrugSorb-ATR Receives FDA Priority Review for Bleeding Reduction in Heart Surgery
3个月前
Acrivon Therapeutics Reports 44% Response Rate for CHK1/2 Inhibitor ACR-368 in Endometrial Cancer Phase II Trial
9个月前
Rakovina Therapeutics Presents AI-Discovered CNS-Penetrant ATR/mTOR Dual Inhibitors at Neuro-Oncology Meeting
去年
FDA Denies CytoSorbents' De Novo Request for DrugSorb-ATR Blood Purification Device
6个月前
Atrogi Doses First Patients in Phase 1 Trial of Exercise-Mimicking Drug ATR-258
2年前
Azitra's ATR-04 Receives FDA Fast Track Designation for EGFRi-Associated Skin Rash
上个月
Aprea Therapeutics Expands Global Patent Portfolio for WEE1 and ATR Precision Oncology Programs
去年
Rakovina Therapeutics Advances Novel AI-Discovered PARP1 and ATR Inhibitors for Hard-to-Treat Cancers
3年前
Repare Therapeutics' ATR Inhibitor Camonsertib Shows Promise in DNA Repair-Deficient Cancers
第 1 页,共 191 页
上一页
下一页